Literature DB >> 16140771

Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.

Michael E Abram1, Michael A Parniak.   

Abstract

Each of the human immunodeficiency virus type 1 (HIV-1) pol-encoded enzymes, protease (PR), reverse transcriptase (RT), and integrase (IN), is active only as a dimer (or higher-order oligomer in the case of IN), but only RT comprises subunits of different masses. RT is a heterodimer of 66-kDa and 51-kDa subunits. The latter is formed by HIV PR-catalyzed cleavage of p66 during virion maturation, resulting in the removal of the RNase H (RNH) domain of a p66 subunit. In order to study the apparent need for RT heterodimers in the context of the virion, we introduced a variety of mutations in the RT p51-RNH protease cleavage site of an infectious HIV-1 molecular clone. Surprisingly, rather than leading to virions with increased RT p66 content, most of the mutations resulted in significantly attenuated virus that contained greatly decreased levels of RT that in many cases was primarily p51 RT. IN levels were also reduced in several mutants. However, most mutants showed normal levels of the Pr160(gag-pol) precursor polyprotein, suggesting that reduced virion RT arose from proteolytic instability rather than decreased incorporation. Mutant virion p24 Gag levels were equivalent to wild type, indicating that Gag incorporation and processing were not affected. Repeated passage of MT-2 cells exposed to mutant viruses led to the appearance of virus with improved replication capacity; these virions contained normally processed RT at near-wild-type levels. These results imply that additional proteolytic processing of RT to the p66/p51 heterodimer is essential to provide proteolytic stability of RT during HIV-1 maturation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140771      PMCID: PMC1212597          DOI: 10.1128/JVI.79.18.11952-11961.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

1.  Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro.

Authors:  A Engelman; R Craigie
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.

Authors:  C Quillent; A M Borman; S Paulous; C Dauguet; F Clavel
Journal:  Virology       Date:  1996-05-01       Impact factor: 3.616

3.  Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing.

Authors:  G Zybarth; C Carter
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

4.  Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain.

Authors:  G Zybarth; H G Kräusslich; K Partin; C Carter
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

5.  Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation.

Authors:  L M Babé; J Rosé; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

6.  Generation and characterization of murine monoclonal antibodies reactive against N-terminal and other regions of HIV-1 reverse transcriptase.

Authors:  X Li; E Amandoron; M A Wainberg; M A Parniak
Journal:  J Med Virol       Date:  1993-03       Impact factor: 2.327

7.  Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active.

Authors:  M Kotler; G Arad; S H Hughes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes.

Authors:  H Lindhofer; K von der Helm; H Nitschko
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

9.  The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases.

Authors:  N Fan; K B Rank; J W Leone; R L Heinrikson; C A Bannow; C W Smith; D B Evans; S M Poppe; W G Tarpley; D J Rothrock
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

10.  Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex.

Authors:  A Engelman; F D Bushman; R Craigie
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  38 in total

1.  The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.

Authors:  Guney Boso; Claes Örvell; Nikunj V Somia
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Reduced fitness in cell culture of HIV-1 with nonnucleoside reverse transcriptase inhibitor-resistant mutations correlates with relative levels of reverse transcriptase content and RNase H activity in virions.

Authors:  Jiong Wang; Robert A Bambara; Lisa M Demeter; Carrie Dykes
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.

Authors:  Isabel Olivares; Alok Mulky; Peter I Boross; József Tözsér; John C Kappes; Cecilio López-Galíndez; Luis Menéndez-Arias
Journal:  J Mol Biol       Date:  2007-07-03       Impact factor: 5.469

Review 4.  HIV-1 Reverse Transcriptase: A Metamorphic Protein with Three Stable States.

Authors:  Robert E London
Journal:  Structure       Date:  2019-01-10       Impact factor: 5.006

5.  6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.

Authors:  Lei Wang; Jing Tang; Andrew D Huber; Mary C Casey; Karen A Kirby; Daniel J Wilson; Jayakanth Kankanala; Jiashu Xie; Michael A Parniak; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Eur J Med Chem       Date:  2018-07-17       Impact factor: 6.514

6.  6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H.

Authors:  Lei Wang; Jing Tang; Andrew D Huber; Mary C Casey; Karen A Kirby; Daniel J Wilson; Jayakanth Kankanala; Michael A Parniak; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Eur J Med Chem       Date:  2018-07-17       Impact factor: 6.514

7.  The p66 immature precursor of HIV-1 reverse transcriptase.

Authors:  Naima G Sharaf; Eric Poliner; Ryan L Slack; Martin T Christen; In-Ja L Byeon; Michael A Parniak; Angela M Gronenborn; Rieko Ishima
Journal:  Proteins       Date:  2014-05-12

8.  Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase.

Authors:  Tatiana V Ilina; Ryan L Slack; John H Elder; Stefan G Sarafianos; Michael A Parniak; Rieko Ishima
Journal:  J Mol Biol       Date:  2018-05-08       Impact factor: 5.469

9.  The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site.

Authors:  Michael E Abram; Stefan G Sarafianos; Michael A Parniak
Journal:  Retrovirology       Date:  2010-02-01       Impact factor: 4.602

10.  The y271 and i274 amino acids in reverse transcriptase of human immunodeficiency virus-1 are critical to protein stability.

Authors:  Hao-Jie Zhang; Yong-Xiang Wang; Hao Wu; Dong-Yan Jin; Yu-Mei Wen; Bo-Jian Zheng
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.